Study Supports Clinical Testing Under Way Across U.S. Early treatment with the experimental antiviral drug…
Browsing: National Institute of Allergy and Infectious Diseases
The National Institute of Allergy and Infectious Diseases (NIAID) is a part of the U.S. National Institutes of Health (NIH) and is primarily responsible for conducting and supporting research to study the causes, treatments, and prevention of infectious and immune-mediated diseases. Established in 1955, NIAID plays a crucial role in responding to emerging public health threats such as the HIV/AIDS epidemic, influenza, tuberculosis, malaria, and more recently, the COVID-19 pandemic. The institute supports a broad range of research from basic science investigating the pathogenesis of disease to clinical trials and vaccine development. NIAID also provides funding to a network of research institutions worldwide. Directed by Dr. Anthony Fauci since 1984, NIAID has been instrumental in promoting better health outcomes and advancements in understanding immune system function and management of infectious diseases. The research conducted and supported by NIAID is pivotal in developing strategies to control and prevent diseases that threaten millions of lives globally.
SARS-CoV-2 stability similar to original SARS virus The virus that causes coronavirus disease 2019 (COVID-19)…
The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness…
Study Enrolling Hospitalized Adults with COVID-19 in Nebraska A randomized, controlled clinical trial to evaluate…
The new cluster of viral pneumonia cases originating in Wuhan, China, marks the third time…
Tesamorelin prevented progression to liver fibrosis in NIH study. Researchers at the National Institutes of…
Few people with peanut allergy tolerate peanut after stopping oral immunotherapy. Continuing with a modest…
Sexually transmitted infections, or STIs, pose a significant public health challenge. Globally, more than one…